欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1756/002
药品名称
Solifenacina Aristo
活性成分
Solifenacin succinate 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Aristo Pharma Iberia, SL
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Poland (PL)
Germany (DE)
Netherlands (NL)
Solifenacin Aristo 10 mg, filmomhulde tabletten
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Solifenacin Aristo 10 mg Filmtabletten
Spain (ES)
Italy (IT)
Slovakia (SK)
Czechia (CZ)
Aristissa
许可日期
2018/04/11
最近更新日期
2024/10/31
药物ATC编码
G04BD08 solifenacin
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_labip_solifenacin_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labip_solifenacin_5mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labop_solifenacin_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_labop_solifenacin_5mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_pl_solifenacin_5_10mg_fct_V01_0120
Date of last change:2024/09/06
Final Product Information
|
common_spc_solifenacin_5_10mg_fct_V01_0120
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase